Status:

COMPLETED

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Lead Sponsor:

Germans Trias i Pujol Hospital

Collaborating Sponsors:

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Conditions:

HIV Infections

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The co-administration of raltegravir with medicinal products that are knouwn to be potent UGT1A1 inhibitors, such as atazanavir, may increase plasma levels of raltegravir. So once daily raltegravir (8...

Detailed Description

Treatment adherence is crucial for the effectiveness of antiretroviral therapy, and, in an attempt to promote treatment adherence by the patients, once daily (QD) regimens are preferred rather than tw...

Eligibility Criteria

Inclusion

  • Patients aged 18 to 65 years old with documented HIV-1 infection.
  • Patients on antiretroviral regimen that includes atazanavir 400mg QD for at least 4 weeks.
  • Complete virological suppression (\<50 copies/mL) for at least 12 months.
  • Voluntary written informed consent.
  • Ability of compliance with visit schedule.

Exclusion

  • AIDS defining condition within 4 weeks prior to the initiation of the study.
  • Concomitant treatment with ritonavir as well as with inducers (NNRTI, rifampin, carbamazepine, phenytoin, phenobarbital, valproic acid, etc) or inhibitors (probenecid, etc) of the uridine diphosphate glucuronyl transferase within 2 weeks before the screening visit.
  • Concomitant therapy with tenofovir.
  • History or suspected poor adherence to HAART.
  • History of drug allergy to raltegravir

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2009

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00718536

Start Date

August 1 2008

End Date

January 1 2009

Last Update

December 5 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Germans Trias i Pujol Hospital

Badalona, Barcelona, Spain, 08916